ReShape Lifesciences Inc/ US76090R2004 /
| 2024-05-20 9:59:36 PM | Chg. +0.0347 | Volume | Bid2:20:28 PM | Ask2:20:28 PM | High | Low |
|---|---|---|---|---|---|---|
| 0.2109USD | +19.67% | 6.08 mill. Turnover: 1.09 mill. |
0.2150Bid Size: 500 | 0.2281Ask Size: 2,900 | 0.2201 | 0.1822 |
GlobeNewswire
05-15
ReShape Lifesciences® Reports First Quarter Ended March 31, 2024 Financial Results and Provides Corp...
GlobeNewswire
05-14
ReShape Lifesciences® to Announce Financial Results for the First Quarter Ended March 31, 2024, and ...
GlobeNewswire
04-01
ReShape Lifesciences® Reports Year Ended December 31, 2023 Financial Results and Provides Corporate ...
GlobeNewswire
03-28
ReShape Lifesciences® Receives Notice of Allowance for Additional U.S. Patent Related to an Intragas...
GlobeNewswire
03-04
ReShape Lifesciences® Provides Update on 2024 Cost Reduction Plan and Reorganization to Prioritize C...
GlobeNewswire
02-22
ReShape Lifesciences® Announces First Surgeries Utilizing Next-Generation Lap-Band® 2.0 FLEX
GlobeNewswire
2023-12-20
ReShape Lifesciences® Engages Maxim Group LLC To Identify Strategic M&A Partnership Alternatives
GlobeNewswire
2023-12-12
ReShape Lifesciences® Receives FDA PMA Supplement Approval for its Next-Generation Lap-Band® 2.0 FLE...
GlobeNewswire
2023-12-12
Alimera Sciences Appoints Todd Wood as President of U.S. Operations and Reports Inducement Grant Und...
GlobeNewswire
2023-11-21
ReShape Lifesciences® Enters into Warrant Exercise Transaction for $1.2 Million in Gross Proceeds
GlobeNewswire
2023-11-08
ReShape Lifesciences® Reports Third Quarter Ended September 30, 2023 Financial Results and 2024 Cost...
GlobeNewswire
2023-11-06
ReShape Lifesciences® to Announce Financial Results for the Third Quarter Ended September 30, 2023 a...
GlobeNewswire
2023-09-22
ReShape Lifesciences® Announces Participation in the LD Micro Main Event XVI
GlobeNewswire
2023-09-21
ReShape Lifesciences® Signs Exclusive License Agreement With Biorad Medisys for Obalon® Gastric Ball...
GlobeNewswire
2023-09-19
ReShape Lifesciences® Significantly Strengthens Patent Portfolio Related to its Obalon® Balloon Syst...
GlobeNewswire
2022-03-28
ReShape Lifesciences™ Reports Year Ended 2021 Financial and Operating Results and Provides Corporate...
GlobeNewswire
2022-03-24
ReShape Lifesciences™ Experiences Continued Momentum of Direct-to-Consumer Marketing Campaign for th...
GlobeNewswire
2022-03-17
ReShape Lifesciences™ to Announce Financial Results for the Year Ended December 31, 2021 and Provide...
GlobeNewswire
2022-01-18
ReShape Lifesciences™ to Participate in the American Society for Metabolic and Bariatric Surgery’s (...
GlobeNewswire
2022-01-13
ReShape Lifesciences Strengthens Leadership Team with Appointment of Michael Bordainick as Senior Vi...
GlobeNewswire
2021-11-16
ReShape Lifesciences Witnesses Great Success with Direct-to-Consumer Marketing Campaign
GlobeNewswire
2021-11-11
ReShape Lifesciences Reports Third Quarter and Nine Month 2021 Financial and Operational Results
